Celgene's Health Scare Is a Wake Up Call for Biotechs

Celgene shareholders got some chilling news Thursday morning, sending its shares plunging 18% when trading opened—the stock’s worst decline in more than a decade.

from WSJ.com: Markets http://ift.tt/2iAmryS
via https://ifttt.com/ IFTTT